作　　者： (高天慧）; (张臻）; (章津铭）; (傅舒）; (傅超美）;

机构地区： 成都中医药大学药学院,中药材标准化教育部重点实验室,中药资源系统研究与开发利用省部共建国家重点实验室培育基地,四川成都611137

出　　处： 《中药与临床》 2017年第2期74-76,F0003,共4页

摘　　要： 附子理中丸为温阳散寒之经方,因其具有传统中药丸剂的经典制备理论与精湛制剂方法作为理论指导与技术支撑,使得该制剂疗效确切,是千百年来治疗脾胃虚寒,呕吐泄泻的居家常备中成药之一。本研究对附子理中丸近年的基础研究报道进行归纳研究,从制剂"毒"与"效"的关系出发,总结其特点与优势,为附子理中丸的基础研究与现代化开发提供参考。 Fuzi Lizhong Pill, a common Chinese patent medicine which contains classic pharmaceutics theory and made by exquisite manufacture method, is always used as an effective Traditional Chinese Medicine for deficiency-cold in spleen and stomach, vomiting and diarrhoea. This study reviews the research of Fuzi Lizhong Pill during recent years, analyzes the comprehensive relationship between ＂toxicity＂ and ＂effect＂ and summarizes the characteristics and superiorities of Fuzi Lizhong Pill. The study provides references for the basic research and development of Fuzi Lizhong Pill.

关 键 词： 附子理中丸 基础研究 增效减毒 临床应用